Panmure Gordon Reiterates “Buy” Rating for Hutchison China MediTech Limited (HCM)
Hutchison China MediTech Limited (LON:HCM)‘s stock had its “buy” rating restated by investment analysts at Panmure Gordon in a note issued to investors on Wednesday. They currently have a GBX 1,200 ($20.13) price objective on the stock. Panmure Gordon’s price target suggests a potential upside of 11.63% from the stock’s previous close.
Shares of Hutchison China MediTech Limited (LON:HCM) opened at 964.9999 on Wednesday. Hutchison China MediTech Limited has a one year low of GBX 740.00 and a one year high of GBX 1115.00. The stock’s 50-day moving average is GBX 967.9 and its 200-day moving average is GBX 842.0.
Hutchison China MediTech Limited (LON:HCM) is a holding company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.